FDi Magazine

CFA Society Toronto Announces Election of 2022-2023 Board Members

Retrieved on: 
Friday, November 18, 2022

Toronto, Nov. 18, 2022 (GLOBE NEWSWIRE) -- CFA Society Toronto is pleased to announce that Mari Jensen, CFA, has been appointed the Chair of the Societys Board of Directors following the 17 November 2022 Annual Meeting.

Key Points: 
  • Toronto, Nov. 18, 2022 (GLOBE NEWSWIRE) -- CFA Society Toronto is pleased to announce that Mari Jensen, CFA, has been appointed the Chair of the Societys Board of Directors following the 17 November 2022 Annual Meeting.
  • I am honoured to serve as the Chair of CFA Society Torontos Board of Directors for the fiscal year 2022-2023.
  • The Society would also like to express our gratitude to departing board members, Robert Cultraro, CFA, Andrew Auerbach, CFA, Paul Hamilton, CFA and Sue Lemon, CFA.
  • CFA Society Toronto represents the interests of more than 11,000 investment professionals in the Greater Toronto Area through advocacy, education, events, and professional development.

Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy

Retrieved on: 
Friday, November 11, 2022

Novotech has significant real-world experience in East-West MRCT strategy after more than 2 decades managing clinical research programs for biotechs across Asia Pacific and the US.

Key Points: 
  • Novotech has significant real-world experience in East-West MRCT strategy after more than 2 decades managing clinical research programs for biotechs across Asia Pacific and the US.
  • Commenting on Novotech's experience, Chief Commercial Officer Barry Murphy said the right drug development pathway supports investor attraction and a successful clinical program.
  • Strategies for an East-West MRCT include:
    - Companies should engage with the US FDA and NMPA early to confirm guidance on their clinical roadmap.
  • Novotech has integrated labs and phase I facilities and provides drug development consulting and clinical development services across all phases.

Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy

Retrieved on: 
Friday, November 11, 2022

Novotech has significant real-world experience in East-West MRCT strategy after more than 2 decades managing clinical research programs for biotechs across Asia Pacific and the US.

Key Points: 
  • Novotech has significant real-world experience in East-West MRCT strategy after more than 2 decades managing clinical research programs for biotechs across Asia Pacific and the US.
  • Commenting on Novotechs experience, Chief Commercial Officer Barry Murphy said the right drug development pathway supports investor attraction and a successful clinical program.
  • Strategies for an East-West MRCT include:
    Companies should engage with the US FDA and NMPA early to confirm guidance on their clinical roadmap.
  • In Asia Pacific Novotech has more than 50 Leading Site Partnership agreements with major medical research institutions which delivers exclusive benefits for sponsors.

The Worldwide Industrial Robotics Industry is Expected to Reach $30.8 Billion by 2027 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 9, 2022

The industrial robotics market is projected to grow from USD 15.7 billion in 2022 to USD 30.8 billion by 2027; it is expected to grow at a CAGR of 14.3% during the forecast period.

Key Points: 
  • The industrial robotics market is projected to grow from USD 15.7 billion in 2022 to USD 30.8 billion by 2027; it is expected to grow at a CAGR of 14.3% during the forecast period.
  • Handling activities such as pick and place, palletizing, packaging, and loading and unloading are common and applicable to most industries.
  • The handling application includes various sub-applications such as material handling, machine tending, as well as bin-picking, which is currently booming.
  • APAC is considered one of the world's major manufacturing hubs and is expected to provide ample growth opportunities to the industrial robotics market.

E-commerce Market in India 2022-2027: Surge in Internet & Smartphone Use Boosts 26.71% Annual Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 8, 2022

The e-commerce market in India was valued at INR 6,210.96 Bn in 2021.

Key Points: 
  • The e-commerce market in India was valued at INR 6,210.96 Bn in 2021.
  • It is anticipated to reach a value of INR 26,459.18 Bn by the end of 2027, expanding at a compound annual growth rate (CAGR) of ~26.71% during the 2022 - 2027 period.
  • The market has grown exponentially over the past five years due to the surge in Internet and smartphone users, improved policy reforms, and increase in disposable income.
  • By 2027, the online retail sector is expected to dominate the e-commerce market in India because of a growing consumer base and increasing FDIs.

Diesel Engine Lubricants Global Market Report 2022: Higher Efficiency and Increased Power Output Than Petrol Engines Driving Adoption - ResearchAndMarkets.com

Retrieved on: 
Friday, November 4, 2022

Diesel engine lubricants are used in heavy machines, construction equipment, commercial vehicles, agricultural machines & equipment, and others.

Key Points: 
  • Diesel engine lubricants are used in heavy machines, construction equipment, commercial vehicles, agricultural machines & equipment, and others.
  • The continued requirement of lubricants in these end-use applications for effective and efficient performance drives the demand for diesel engine lubricants.
  • Increasing demand for heavy vehicles and construction equipment will drive the growth of diesel engine lubricants globally.
  • The global diesel engine lubricants market is highly influenced by the supply and demand scenario of the overall lubricants.

Clinical Research Opportunities in China and the Path to USFDA Approval – Whitepaper

Retrieved on: 
Sunday, October 30, 2022

The report was prepared for international biotechs considering China for their clinical research, as well as China biotechs conducting research in China, and the relevant processes required for USFDA approvals.

Key Points: 
  • The report was prepared for international biotechs considering China for their clinical research, as well as China biotechs conducting research in China, and the relevant processes required for USFDA approvals.
  • Novotechs Vice President, Global Head of Clinical Services Dr. Yooni Kim said:
    China presents exceptional clinical opportunities with vast populations and word-class research facilities and KOLs.
  • This concise analysis of the pathway to USFDA approval expertly informs clinical stage biotechs about the China research benefits and how to manage any challenges.
  • The report details the regulatory requirements for biotechs including NDA and IND processes as well as ex-US research guidance for a successful USFDA approval pathway.

Clinical Research Opportunities in China and the Path to USFDA Approval - Whitepaper

Retrieved on: 
Tuesday, October 25, 2022

The report was prepared for international biotechs considering China for their clinical research, as well as China biotechs conducting research in China, and the relevant processes required for USFDA approvals.

Key Points: 
  • The report was prepared for international biotechs considering China for their clinical research, as well as China biotechs conducting research in China, and the relevant processes required for USFDA approvals.
  • Novotech's Vice President, Global Head of Clinical Services Dr. Yooni Kim said: "China presents exceptional clinical opportunities with vast populations and word-class research facilities and KOLs.
  • This concise analysis of the pathway to USFDA approval expertly informs clinical stage biotechs about the China research benefits and how to manage any challenges.
  • The report details the regulatory requirements for biotechs including NDA and IND processes as well as ex-US research guidance for a successful USFDA approval pathway.

Liquidity and Asset Liability Management Solutions Global Market Report 2022: Integration of Artificial Intelligence with Liquidity Asset Liability Management Platforms to Shape Future Growth

Retrieved on: 
Thursday, October 27, 2022

North America leads in the global liquidity and asset liability management solutions market share, followed by Europe.

Key Points: 
  • North America leads in the global liquidity and asset liability management solutions market share, followed by Europe.
  • These factors are contributing to the liquidity and asset liability management solutions market growth in this region.
  • Based on the liquidity and asset liability management solutions market report, the liquidity and asset liability management solutions market is segmented into component and industry.
  • Based on industry, the liquidity and asset liability management solutions market is segmented into banks, brokers, specialty finance, wealth advisors, and others.

Liquidity and Asset Liability Management Solutions Global Market Report 2022: Increasing Credit Risk Across Financial Institutions Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 18, 2022

North America leads in the global liquidity and asset liability management solutions market share, followed by Europe.

Key Points: 
  • North America leads in the global liquidity and asset liability management solutions market share, followed by Europe.
  • These factors are contributing to the liquidity and asset liability management solutions market growth in this region.
  • Based on the liquidity and asset liability management solutions market report, the liquidity and asset liability management solutions market is segmented into component and industry.
  • Based on industry, the liquidity and asset liability management solutions market is segmented into banks, brokers, specialty finance, wealth advisors, and others.